Walking is known to improve arthritis symptoms, physical function, gait speed, and quality of life. Despite the known benefits, people with arthritis aren't walking enough. According to a report in Morbidity and Mortality Weekly, 53% of arthritis patients didn't walk at all (0 minutes per week). Read more...
It is a misconception that Sjogren's syndrome is a relatively benign autoimmune condition. In fact, primary Sjogren's syndrome is associated with serious complications. Read more...
A sedentary lifestyle, medication side effects, and a poor diet can contribute to weight gain. How much do you know about maintaining ideal weight and weight loss? Take the Arthritis and Weight Loss Quiz...
Orencia (abatacept) is a biologic drug approved for the treatment of moderate to severe rheumatoid arthritis in adults and the treatment of moderate to severe polyarticular juvenile idiopathic arthritis in children 6 years old and older. Orencia is not a TNF blocker. Read more...
Sign up for more free newsletters on your favorite topics
You are receiving this newsletter because you subscribed to the About.com Arthritis & Joint Conditions newsletter. If you wish to change your email address or unsubscribe, please click here.
Walking is known to improve arthritis symptoms, physical function, gait speed, and quality of life. Despite the known benefits, people with arthritis aren't walking enough. According to a report in Morbidity and Mortality Weekly, 53% of arthritis patients didn't walk at all (0 minutes per week). 
It is a misconception that Sjogren's syndrome is a relatively benign autoimmune condition. In fact, primary Sjogren's syndrome is associated with serious complications. 
A sedentary lifestyle, medication side effects, and a poor diet can contribute to weight gain. How much do you know about maintaining ideal weight and weight loss? Take the 
Orencia (abatacept) is a biologic drug approved for the treatment of moderate to severe rheumatoid arthritis in adults and the treatment of moderate to severe polyarticular juvenile idiopathic arthritis in children 6 years old and older. Orencia is not a TNF blocker. 
Nema komentara:
Objavi komentar